ATS 2019 Virtual Final Program

P175 Predictors of Mortality for Patients with Fibrotic Interstitial Lung Disease Mechanically Ventilated for Acute Respiratory Failure/ M. Martin, T. Moua, Rochester, MN, p.A3361 P176 Prognostic Score of Acute Exacerbation (AE) in Idiopathic Interstitial Pneumonias (IIPs) (AE-IIPs) to Evaluate Treatment for AE-IIPs/ T. Arai, C. Sugimoto, S. Tokura, N. Takeuchi, T. Kagawa, Y. Inoue, K. Tachibana, T. Okuma, M. Akira, S. Hayashi, Y. Inoue, Sakai, Japan, p.A3362 P177 The Comparision of High Resolution Tomography Patterns in Familial Pulmonary Fibrosis/ D. Estrella, E. Viana Mancuzo, R. Amorim, Belo Horizonte, Brazil, p.A3363 P178 Longitudinal Comparison of Anxiety and Depression Between Idiopathic Pulmonary Fibrosis (IPF) and Non-IPF Interstitial Lung Disease: A Prospective Cohort Study/ W. Bae, J. Cho, J. Lee, Y.S. Park, C.-H. Lee, S.-M. Lee, J.-J. Yim, C.-G. Yoo, Y.W. Kim, S.K. Han, S.M. Choi, Seoul, Korea, Republic of, p.A3364 P179 Changes in Pulmonary Function Test Results Within 1 st 2 Years of Monitoring as Predictor of Long Term Decline in Pulmonary Function/ K.K.H. Wong, G. Gutierrez, J. Williams, Washington, DC, p.A3365 P180 Cardiopulmonary Exercise Testing as a Longitudinal Clinical Tool in Interstitial Lung Disease Management/ L. Markham, O. Tomlinson, R. Wollerton, B.A. Knight, A. Duckworth, A. Spiers, C.A. Williams, M.A. Gibbons, C.J. Scotton, Exeter, United Kingdom, p.A3366 P181 A Clinocopathological Study of Lung Cancer in Patients with Non-Idiopathic Pulmonary Fibrosis (IPF) Diffuse Parenchymal Lung Diseases/ S. Fedyna, W. Bulman, C. Shu, A. Saqi, J. Sonett, P. Stanifer, New York, NY, p.A3367 Facilitator : T.J. Huie, MD, Denver, CO P182 Patterns of Exacerbations in Combined Pulmonary Fibrosis and Emphysema versus Idiopathic Pulmonary Fibrosis/ M. Zantah, Y. Dotan, C. Dass, N. Marchetti, H. Zhao, G.J. Criner, Philadelphia, PA, p.A3368 P183 Acute Exacerbation of Idiopathic Interstitial Pneumonias: Retrospective Analysis of Survivors/ T. Takihara, Y. Horio, K. Enokida, M. Takahashi, F. Takahashi, K. Niimi, N. Hayama, T. Oguma, T. Aoki, K. Asano, Kanagawa, Japan, p.A3369 P184 Interstitial Lung Disease Among US Veterans: Pilot Study of a Prospective Registry/ A. Ahuja, N. Wadhwa, M. Salvatore, R. Roy, N.A. Hasaneen, Stony Brook, NY, p.A3370 P185 Comparison of MRC Breathlessness Scale to a Novel Multidimensional Dyspnea Scale (MDDS) for Clinical Use/ M. Kalluri, J. Bakal, W. Ting, S. Younus, Edmonton, Canada, p.A3371 P186 Blood Monocyte Count as a Prognostic Marker in Idiopathic Pulmonary Fibrosis: An Australian IPF Registry Analysis/ A. Teoh, H. Jo, K. Symons, E. Ray, I. Glaspole, N. Goh, C. Grainge, P. Hopkins, C.J. Zappala, K. Gregory, W. Cooper, A. Mahar, H. Walters, P.N. Reynolds, S. Chapman, S. Ellis, Y.I. Moodley, M. Sacha, T.J. Corte, Sydney, Australia, p.A3372 P187 Clinical Examination Classified with Serum SP-D Level in Patients with Organizing Pneumonia/ H. Matsuse, C. Nakano, N. Kodaka, Tokyo, Japan, p.A3373 P188 Postoperative Acute Exacerbation of Interstitial Pneumonia in Pulmonary <and> for > Non-Pulmonary Surgery: A Retrospective Study/ T. Miyamura, N. Sakamoto, T. Kakugawa, D. Okuno, H. Yura, S. Nakashima, H. Ishimoto, D. Taniguchi, T. Miyazaki, T. Tsuchiya, H. Yamaguchi, Y. Obase, Y. Ishimatsu, T. Nagayasu, H. Mukae, Nagasaki, Japan, p.A3374 P189 Clinical Features of Smoking-Related Unclassifiable Interstitial Pneumonia/ A. Fukada, M. Toyoshima, T. Nozue, T. Suda, Hamamatsu, Japan, p.A3375 P190 Contributory Factors and Prevalence of Obstructive Sleep Apnea in Patients with Interstitial Lung Disease in Korea/ J.H. Lee, Busan, Korea, Republic of, p.A3376 P191 Baseline Serum Lactate Dehydrogenase and %VC May Predict the Short Time Decline of FVC in Patients with Idiopathic Pulmonary Fibrosis/ T. Nikaido, Y. Tanino, Y. Sato, R. Togawa, T. Kawamata, M. Saito, N. Watanabe, T. Umeda, M. Rikimaru, Y. Suzuki, M. Uematsu, H. Minemura, A. Fukuhara, S. Sato, J. Saito, K. Kanazawa, Y. Shibata, Fukushima, Japan, p.A3377 P192 Evaluation of Different UIP Patterns on CT Scans in Patients with Idiopathic Pulmonary Fibrosis/ B. Wang, A. Chughtai, D. Vummidi, E. Kazerooni, M. Xia, S. Murray, M.L. Salisbury, J.S.V. Sheth, C. Holtze, E.S. White, E. Belloli, K.R. Flaherty, Ann Arbor, MI, p.A3378 P193 Retrospective Analysis of Prognostic Factors for Acute Exacerbation of Idiopathic Interstitial Pneumonias/ K. Enokida, T. Takihara, Y. Horio, M. Takahashi, F. Takahashi, K. Niimi, N. Hayama, T. Oguma, T. Aoki, K. Asano, Isehara, Kanagawa, Japan, p.A3379 Facilitator : B. Collins, MD, Seattle, WA P194 Changes in Pulmonary Artery to Ascending Aorta Ratio and Impact on Mortality in Idiopathic Pulmonary Fibrosis/ T. Maeda, M.F. Siddiqi, M. Salvatore, M.L. Padilla, D. Steiger, New York, NY, p.A3381 P195 Clinical Courses of Asymptomatic Patients with Mild Idiopathic Pleuroparenchymal Fibroelastosis/ M. Toyoshima, A. Fukada, T. Nozue, T. Suda, Hamamatsu, Japan, p.A3382 P196 KL-6 as Idiopathic Pulmonary Fibrosis (IPF) Biomarker: A Retrospective Cohort Study in 92 IPF Patients and 120 Healthy Controls/ C. Albera, A. Cornio, A. Mezzina, G. Verri, F. Crosa, G. Priolo, P. Pellegatta, M. Ardissone, A. Perego, K. Walton, Torino, Italy, p.A3383 P197 White Blood Cell Count and Hospitalization as Additive Prognostic Indicators in Idiopathic Pulmonary Fibrosis/ A.W. Brown, J. Peterson, J.M. Cheng, B. Cannon, C.S. King, S.D. Nathan, Falls Church, VA, p.A3384 P198 Serial Change in the White Blood Cell Count as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis/ A.W. Brown, J. Peterson, J.M. Cheng, F.S.N. Soares, S. Aryal, K. Ahmad, M. Koslow, N.A. Weir, O.A. Shlobin, C.S. King, S.D. Nathan, Falls Church, VA, p.A3385 P199 Weight Loss as a Predictor of Mortality in Patients with Interstitial Lung Disease/ J.V. Pugashetti, J. Graham, N. Boctor, C. Mendez, E. Foster, M. Juarez, R.W. Harper, B.M. Morrissey, M. Kadoch, J. Oldham, Sacramento, CA, p.A3386 ATS 2019 • Dallas, TX 164 MONDAY • MAY 20